Suppr超能文献

(R)-α-甲基组胺对去脑豚鼠交感神经心升压反应抑制作用的药理学特性

Pharmacological characterization of the inhibitory effect of (R)-alpha-methylhistamine on sympathetic cardiopressor responses in the pithed guinea-pig.

作者信息

Hutchison R W, Hey J A

机构信息

Schering-Plough Research Institute, Kenilworth, NJ 07033-9539.

出版信息

J Auton Pharmacol. 1994 Dec;14(6):393-402. doi: 10.1111/j.1474-8673.1994.tb00620.x.

Abstract
  1. The effect of (R)-alpha-methylhistamine (R-alpha-mHA), a selective histamine H3-receptor agonist, on increases in blood pressure and heart rate mediated by activation of the sympathetic nervous system induced by electrical stimulation of the spinal cord, was characterized in the vagotomized, pithed guinea-pig. 2. The frequency-dependent nature of (R)-alpha-mHA's effect on sympathetic cardiopressor responses was studied at frequencies between 1 and 20 Hz. (R)-alpha-mHA (10-100 micrograms kg-1, i.v.) produced a dose-dependent inhibition of the stimulated increase in both blood pressure (BP) and heart rate (HR). The inhibition was inversely related to frequency and maximum inhibition (BP, 61% at 1 Hz; HR, 50% at 1 Hz) was seen with 100 micrograms kg-1 of (R)-alpha-mHA. Treatment with the H3 receptor inactive stereoisomer, (S)-alpha-methylhistamine (300 micrograms kg-1, i.v.) did not inhibit the neurogenic sympathetic cardiopressor responses. 3. Pretreatment with thioperamide (1 mg kg-1, i.v.), a histamine H3 receptor antagonist, blocked (R)-alpha-mHA's inhibitory effect on stimulation-induced sympathetic cardiopressor responses. 4. Combined pretreatment with the H2-receptor antagonist cimetidine (3 mg kg-1, i.v.) and the H1-receptor antagonist chlorpheniramine (0.3 mg kg-1, i.v.) did not attenuate (R)-alpha-mHA's inhibitory effects. 5. (R)-alpha-mHA (100 micrograms kg-1) had no effect on the hypertensive or tachycardia effects induced by adrenaline (1 and 3 micrograms kg-1, i.v.). 6. Treatment with a combination of prazosin (1 mg kg-1, i.v.) and yohimbine (1.5 mg kg-1, i.v.) to block alpha 1- and alpha 2-adrenoceptors, abolished the sympathetic hypertension without affecting the inhibition of sympathetic tachycardia induced by (R)-alpha-mHA. Conversely, pretreatment with the beta-adrenoceptor antagonist propranolol (1 mg kg-1, i.v.), which blocked the sympathetic tachycardia, did not block (R)-alpha-mHA's inhibition of sympathetic hypertensive responses. 7. In adrenalectomized guinea-pigs, (R)-alpha-mHA (100 micrograms kg-1, i.v.) also produced a frequency-dependent inhibition of sympathetic hypertensive cardiopressor responses that was not significantly different from intact animals. 8. These results demonstrate that (R)-alpha-mHA produces a frequency-dependent inhibition of the cardiopressor responses due to activation of the sympathetic innervation to the resistance vessels and the heart.(ABSTRACT TRUNCATED AT 400 WORDS)
摘要
  1. 在切断迷走神经、脊髓毁损的豚鼠中,研究了选择性组胺H3受体激动剂(R)-α-甲基组胺(R-α-mHA)对脊髓电刺激诱导的交感神经系统激活所介导的血压升高和心率加快的影响。2. 研究了(R)-α-mHA对交感缩血管反应的频率依赖性效应,刺激频率为1至20Hz。(R)-α-mHA(10 - 100微克/千克,静脉注射)对刺激引起的血压(BP)和心率(HR)升高产生剂量依赖性抑制。这种抑制与频率呈负相关,100微克/千克的(R)-α-mHA产生最大抑制(BP在1Hz时为61%;HR在1Hz时为50%)。用H3受体无活性的立体异构体(S)-α-甲基组胺(300微克/千克,静脉注射)处理未抑制神经源性交感缩血管反应。3. 用组胺H3受体拮抗剂硫丙酰胺(1毫克/千克,静脉注射)预处理可阻断(R)-α-mHA对刺激诱导的交感缩血管反应的抑制作用。4. 联合用H2受体拮抗剂西咪替丁(3毫克/千克,静脉注射)和H1受体拮抗剂氯苯那敏(0.3毫克/千克,静脉注射)预处理并未减弱(R)-α-mHA的抑制作用。5. (R)-α-mHA(100微克/千克)对肾上腺素(1和3微克/千克,静脉注射)诱导的高血压或心动过速效应无影响。6. 用哌唑嗪(1毫克/千克,静脉注射)和育亨宾(1.5毫克/千克,静脉注射)联合处理以阻断α1和α2肾上腺素受体,可消除交感神经高血压,但不影响(R)-α-mHA诱导的交感神经心动过速的抑制作用。相反,用β肾上腺素受体拮抗剂普萘洛尔(1毫克/千克,静脉注射)预处理可阻断交感神经心动过速,但不阻断(R)-α-mHA对交感神经高血压反应的抑制作用。7. 在肾上腺切除的豚鼠中,(R)-α-mHA(100微克/千克,静脉注射)也产生频率依赖性的交感神经高血压缩血管反应抑制作用,与完整动物无显著差异。8. 这些结果表明,(R)-α-mHA由于对阻力血管和心脏的交感神经支配激活而产生频率依赖性的缩血管反应抑制作用。(摘要截短至400字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验